GSK in China: 13 Years Later
GSK in China: 13 Years Later revisits one of the most significant corporate compliance scandals of the modern era and explores why its lessons still matter today. This series examines how failures in culture, third-party oversight, incentives, and leadership can turn business ambition into legal and reputational disaster. Through a compliance lens, each episode connects the facts of the GSK case to the challenges companies continue to face around ethics, accountability, and effective corporate governance. For compliance professionals, business leaders, and anyone interested in organizational integrity, this podcast offers a practical look at what the scandal still teaches us about building a culture that can withstand pressure.
1
Anti-Corruption Enforcement and the Compliance ...
ABC Enforcement and the Compliance Imperative.
23 min
2
Compliance Lessons Learned
What are the compliance lessons learned from GSK in China?
24 min
3
From Compliance Crisis to Business Redesign: GS...
How did GSK rebuild it's business in China?
22 min
4
After the Humphreys Verdict: Managing Third-Par...
What DD can you actually do in China?
22 min
5
The Verdicts
What were the Verdicts and what did they mean?
23 min
6
Whistleblower Emails, a Sex Tape, and the Compl...
The Sex Tape and Internal Investigations in China.
19 min
7
Where Was the Board? Director Oversight and Doi...
The role of the Board of Directors in the GSK in China scandal.
22 min
8
How “Good Fraud” Bypassed Audits, Compliance, a...
How did GSK miss such obvious red flags?
22 min
9
GSK in China: The Compliance Breakdown That Sti...
An introduction to the compliance scandal involving GSK in China.
22 min